List of bibliographic references indexed by tolerability
Number of relevant bibliographic references: 27.
[0-20] [
0 - 20][
0 - 27][
20-26][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000345 (2015) |
Adriana Prundean [France] ; Katia Youssov ; Sandrine Humbert ; Dominique Bonneau ; Christophe Verny | A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease. |
| 000424 (2014) |
Sylvia Boesch [Autriche] ; Wolfgang Nachbauer ; Caterina Mariotti ; Francesco Sacca ; Alessandro Filla ; Thomas Klockgether ; Thomas Klopstock ; Ludger Schöls ; Heike Jacobi ; Boriana Büchner ; Jennifer Müller Vom Hagen ; Lorenzo Nanetti ; Karen Manicom | Safety and tolerability of carbamylated erythropoietin in Friedreich's ataxia. |
| 000844 (2013) |
| Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD). |
| 001938 (2010) |
Tanya Simuni [États-Unis] ; Emily Borushko [États-Unis] ; Michael J. Avram [États-Unis] ; Scott Miskevics [États-Unis] ; Audrey Martel [États-Unis] ; C. Zadikoff [États-Unis] ; Aleksandar Videnovic [États-Unis] ; Frances M. Weaver [États-Unis] ; Karen Williams [États-Unis] ; D. James Surmeier [États-Unis] | Tolerability of isradipine in early Parkinson's disease: A pilot dose escalation study |
| 001A20 (2010) |
| Safety and tolerability of high‐dosage coenzyme Q10 in Huntington's disease and healthy subjects |
| 001D19 (2010) |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
| 001F15 (2010) |
| Safety and Tolerability of High-Dosage Coenzyme Q10 in Huntington's Disease and Healthy Subjects |
| 002B91 (2007) |
Björn Holmberg [Suède] ; Jan-Ove Johansson [Suède] ; Werner Poewe [Autriche] ; Gregor Wenning [Autriche] ; Niall P. Quinn [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Eduardo Tolosa [Espagne] ; Adriana Cardozo [Espagne] ; Nil Dizdar [Suède] ; Olivier Rascol [France] ; Tarik Slaoui [France] | Safety and tolerability of growth hormone therapy in multiple system atrophy: A double‐blind, placebo‐controlled study |
| 002D62 (2007) |
Ron L. Alterman [États-Unis] ; Jay L. Shils [États-Unis] ; Joan Miravite [États-Unis] ; Michele Tagliati [États-Unis] | Lower stimulation frequency can enhance tolerability and efficacy of pallidal deep brain stimulation for dystonia |
| 002D66 (2007) |
Christopher Kenney [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis] | Long‐term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders |
| 002E65 (2007) |
Günther Deuschl [Allemagne] ; Antanas Vaitkus [Lituanie] ; Gabriele-Cornelia Fox ; Torsten Roscher ; Dieter Schremmer [Allemagne] ; Ariel Gordin | Efficacy and tolerability of entacapone versus cabergoline in parkinsonian patients suffering from wearing‐off |
| 003302 (2006) |
Joseph H. Friedman [États-Unis] ; Robert M. Berman [États-Unis] ; Christopher G. Goetz [États-Unis] ; Stewart A. Factor [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; William H. Carson [États-Unis] ; Ronald N. Marcus [États-Unis] | Open‐label flexible‐dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease |
| 003551 (2006) |
Richard Dubinsky [États-Unis] ; Carolyn Gray [États-Unis] | CYTE‐I‐HD: Phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's disease |
| 003A45 (2005) |
Steven J. Frucht [États-Unis] ; Yvette Bordelon [États-Unis] ; William H. Houghton [États-Unis] ; Dayton Reardan [États-Unis] | A pilot tolerability and efficacy trial of sodium oxybate in ethanol‐responsive movement disorders |
| 003C14 (2004) |
Adrian Handforth [États-Unis] ; Fredricka C. Martin [États-Unis] | Pilot efficacy and tolerability: A randomized, placebo‐controlled trial of levetiracetam for essential tremor |
| 004932 (2000) |
Silvana Tesei [Italie] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Anna Zecchinelli [Italie] ; Claudio B. Mariani [Italie] ; Gianni Pezzoli [Italie] | Tolerability of paroxetine in Parkinson's disease: A prospective study |
| 004B98 (1999) |
| Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients. Tolcapone Study Group. |
| 004D55 (1999) |
| Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa‐treated parkinsonian patients |
| 004E53 (1999) |
| Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated Parkinsonian patients |
| 005093 (1998) |
Robert A. Hauser [États-Unis] ; Eric Molho [États-Unis] ; Heidi Shale [États-Unis] ; Simon Pedder [États-Unis] ; Ernest E. Dorflinger [États-Unis] | A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients |
| 005370 (1997) |
Sampaio ; Joaquim J. Ferreira ; Fernanda Sim Es [Portugal] ; Maria J. Rosas [Portugal] ; Marina Magalhães [Portugal] ; Ana P. Correia [Portugal] ; Ant Nio Bastos-Lima [Portugal] ; Rairnundo Martins [Portugal] ; Alexandre Castro-Caldas | DYSBOT: A single‐blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1 |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "tolerability"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "tolerability" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= tolerability
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
